glp 1 and probiotics Pendulum GLP-1 Probiotic Pro Bifidobacterium infantis GLP-Pro | GLP-1 Probiotic &

Data availability The datasets generated and/or analyzed during this study are not publicly available because they are stored on the corresponding authors personal account on the Stampede3 supercomputer

The company announced that it had the data needed to initiate global regulatory submissions for the drug

DOAC As of early 2026, only one interventional trial has directly compared the efficacy and safety of two widely prescribed DOACs

For a complete list of potential side effects, visit the drug manufacturer websites for: Saxenda (liraglutide), Wegovy (semaglutide), and Zepbound (tirzepatide), the three GLP-1 medications that are FDA-approved for overweight and obesity